Cellumed Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 1.60%

Cellumed Co. Ltd (049180) has an Asset Resilience Ratio of 1.60% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 049180 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

₩1.14 Billion
≈ $774.35K USD Cash + Short-term Investments

Total Assets

₩71.62 Billion
≈ $48.54 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2008–2024)

This chart shows how Cellumed Co. Ltd's Asset Resilience Ratio has changed over time. See what is Cellumed Co. Ltd's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Cellumed Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 049180 market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩1.14 Billion 1.6%
Total Liquid Assets ₩1.14 Billion 1.60%

Asset Resilience Insights

  • Limited Liquidity: Cellumed Co. Ltd maintains only 1.60% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Cellumed Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Cellumed Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Caina Technology Co. Ltd.
SHE:301122
Medical Instruments & Supplies 23.52%
Mark Dynamics Indonesia Tbk PT
JK:MARK
Medical Instruments & Supplies 6.64%
GETS Global Bhd
KLSE:5079
Medical Instruments & Supplies 0.03%
QITIAN Technology Group Co Ltd
SHE:300061
Medical Instruments & Supplies 0.00%
Sartorius Aktiengesellschaft
XETRA:SRT3
Medical Instruments & Supplies 4.48%
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
Medical Instruments & Supplies 29.19%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 4.42%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 51.82%

Annual Asset Resilience Ratio for Cellumed Co. Ltd (2008–2024)

The table below shows the annual Asset Resilience Ratio data for Cellumed Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.05% ₩34.26 Million
≈ $23.22K
₩70.22 Billion
≈ $47.59 Million
-0.88pp
2023-12-31 0.93% ₩619.54 Million
≈ $419.85K
₩66.47 Billion
≈ $45.05 Million
-9.96pp
2022-12-31 10.90% ₩10.16 Billion
≈ $6.89 Million
₩93.26 Billion
≈ $63.20 Million
-15.10pp
2021-12-31 25.99% ₩25.05 Billion
≈ $16.98 Million
₩96.37 Billion
≈ $65.31 Million
-6.39pp
2020-12-31 32.38% ₩22.93 Billion
≈ $15.54 Million
₩70.80 Billion
≈ $47.98 Million
-0.31pp
2019-12-31 32.69% ₩21.24 Billion
≈ $14.40 Million
₩64.98 Billion
≈ $44.04 Million
+16.18pp
2018-12-31 16.51% ₩8.18 Billion
≈ $5.55 Million
₩49.58 Billion
≈ $33.60 Million
+13.02pp
2017-12-31 3.48% ₩2.26 Billion
≈ $1.53 Million
₩64.98 Billion
≈ $44.04 Million
-5.63pp
2016-12-31 9.11% ₩6.36 Billion
≈ $4.31 Million
₩69.79 Billion
≈ $47.30 Million
+5.37pp
2015-12-31 3.74% ₩3.07 Billion
≈ $2.08 Million
₩82.00 Billion
≈ $55.57 Million
+2.85pp
2014-12-31 0.88% ₩622.65 Million
≈ $421.96K
₩70.40 Billion
≈ $47.71 Million
-0.83pp
2013-12-31 1.72% ₩1.34 Billion
≈ $905.58K
₩77.78 Billion
≈ $52.71 Million
+0.71pp
2012-12-31 1.01% ₩835.60 Million
≈ $566.27K
₩82.59 Billion
≈ $55.97 Million
-2.32pp
2011-12-31 3.33% ₩2.64 Billion
≈ $1.79 Million
₩79.25 Billion
≈ $53.70 Million
+2.97pp
2008-12-31 0.37% ₩230.00 Million
≈ $155.87K
₩62.32 Billion
≈ $42.23 Million
--
pp = percentage points

About Cellumed Co. Ltd

KQ:049180 Korea Medical Instruments & Supplies
Market Cap
$37.57 Million
₩55.44 Billion KRW
Market Cap Rank
#22905 Global
#1592 in Korea
Share Price
₩1009.00
Change (1 day)
-9.10%
52-Week Range
₩570.00 - ₩2570.00
All Time High
₩36700.00
About

Cellumed Co.,Ltd., a biotechnology company, provides bone graft materials, medical devices, and cosmeceuticals in South Korea. The company offers CLnZyme, a mRNA enzyme; cosmeceuticals, such as FGF7 for skin regeneration and TGFß-1 for tissue regeneration; and electric motorcycles. It provides tissue bank products, such as celluderm powder, ultra, and HD implant for the skin; patellar tendon hemi… Read more